Prime Medicine, Inc. (PRME)
3.255
-0.14
(-3.98%)
USD |
NASDAQ |
Aug 24, 16:00
3.26
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Debt to Equity Ratio : 2.825 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.825 |
| March 31, 2026 | 1.493 |
| December 31, 2025 | 0.9633 |
| September 30, 2025 | 0.73 |
| June 30, 2025 | 1.967 |
| March 31, 2025 | 1.133 |
| December 31, 2024 | 0.2664 |
| September 30, 2024 | 0.2177 |
| June 30, 2024 | 0.2115 |
| March 31, 2024 | 0.1797 |
| December 31, 2023 | 0.1024 |
| September 30, 2023 | 0.0879 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.106 |
| March 31, 2023 | 0.0931 |
| December 31, 2022 | 0.0909 |
| September 30, 2022 | 0.182 |
| June 30, 2022 | 0.173 |
| March 31, 2022 | 0.0354 |
| December 31, 2021 | 0.0434 |
| September 30, 2021 | 0.0323 |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Beam Therapeutics, Inc. | 0.2317 |
| Twist Bioscience Corp. | 0.21 |
| Sana Biotechnology, Inc. | 0.4771 |
| Generate Biomedicines, Inc. | 0.1373 |
| Intellia Therapeutics, Inc. | 0.1009 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 249.04M |
| Total Liabilities (Quarterly) | 209.23M |
| Shareholders Equity (Quarterly) | 39.81M |
| Current Ratio | 3.054 |
| Net Debt Paydown Yield | 0.26% |